Wassross-CV-20
Description_Effects
Wassross-CV-20 is a combination medicine consisting of Rosuvastatin and Clopidogrel, used primarily to reduce the risk of heart attack and stroke in patients who are at increased risk due to cardiovascular conditions. Rosuvastatin belongs to the class of drugs called statins, which work by lowering levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol, as well as triglycerides in the blood. At the same time, Rosuvastatin helps increase high-density lipoprotein (HDL) cholesterol, or "good" cholesterol. By improving this balance, Rosuvastatin helps reduce the buildup of fatty plaques in the arteries, a condition known as atherosclerosis, which can lead to narrowing and blockage of blood vessels. This reduces the likelihood of cardiovascular events like heart attacks or strokes. Clopidogrel is an antiplatelet medication that helps prevent blood cells called platelets from clumping together to form clots. Blood clots can block arteries and cause serious events such as heart attacks or strokes. By inhibiting platelet aggregation, Clopidogrel reduces the risk of clot formation and improves blood flow in the arteries. Together, these medicines offer a dual approach to cardiovascular protection by both managing cholesterol levels and preventing blood clots. It is essential to take Wassross-CV-20 exactly as prescribed by a healthcare professional and continue treatment consistently to maintain its benefits. Regular monitoring may be required to check cholesterol levels and overall cardiovascular health while on this medication. Stopping the medication without medical advice can increase the risk of serious heart problems.
